ROYALTY PHARMA PLC shareholders Q3 2023

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
EASTERN BANK 76,983$2,089,3260.10%
SECTORAL ASSET MANAGEMENT INC 17,950$487,1630.10%
Man Group plc 1,133,615$30,766,3110.10%
AIGEN INVESTMENT MANAGEMENT, LP 17,943$486,9730.09%
US FINANCIAL ADVISORS, LLC 8,165$221,5980.09%
MIRABELLA FINANCIAL SERVICES LLP 24,452$663,6280.09%
China Universal Asset Management Co., Ltd. 11,523$3130.09%
Engineers Gate Manager LP 90,163$2,447,0240.09%
GLENMEDE TRUST CO NA 501,680$13,615,5950.08%
FMR LLC 30,427,172$825,793,4570.07%
Y-Intercept (Hong Kong) Ltd 26,862$729,0350.07%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1,953,242$53,0110.06%
Squarepoint Ops LLC 956,556$25,960,9300.06%
Point72 Asset Management, L.P. 728,200$19,763,3480.06%
TUDOR INVESTMENT CORP ET AL 208,873$5,668,8130.06%
Petrus Trust Company, LTA 17,714$480,7580.05%
First Trust Direct Indexing L.P. 16,044$435,4340.05%
LOS ANGELES CAPITAL MANAGEMENT LLC 431,546$11,712,1580.05%
Kovitz Investment Group Partners, LLC 100,666$2,732,0750.05%
Bank Pictet & Cie (Europe) AG 50,000$1,357,0000.05%
External links

This page lists ROYALTY PHARMA PLC's shareholders in Q3 2023. To view ROYALTY PHARMA PLC's shareholder history, click here.